Madhavi Gavini

Madhavi Gavini has extensive experience in the field of biophysics and therapeutic development. Madhavi is the CEO and Founder of Droplette since 2017. Prior to this, they worked at Novopyxis from 2013-2017 as the President and Cofounder, where they developed a patent-pending portfolio of novel therapeutics and drug delivery systems. Madhavi focused on engineering transdermal delivery devices for cosmetics applications and rare diseases. Before that, Madhavi was a Cofounder at Integrative Enzymatics from 2011-2013. In 2010, they worked as a Visiting Graduate Student at the Computational Biophysics Group, studying the monomeric structure of amyloid beta protein. Overall, Madhavi Gavini's work experience showcases their expertise in leadership, entrepreneurship, and scientific research.

Madhavi Gavini's education history includes studying Mathematics at the Massachusetts Institute of Technology. However, no information is provided regarding the specific years or degree obtained. Additionally, Madhavi Gavini pursued a field of study in Neuroscience at The Johns Hopkins University. Again, specific details such as start and end years, as well as degree attainment, are not given.